Carbonyl Compounds Produced by Vaporizing Cannabis Oil Thinning Agents

Journal of Alternative and Complementary Medicine

Volumn 23, Issue 11, 2017, Pages 879-884

  Troutt, William D ^a   Didonato, Matthew D ^a  

^a Medical Marijuana Research Institute   (United States)

Author keywords

cannabis oil; cannabis thinning agents; cannabis vaporization; carbonyl production

Indexed keywords

ACETALDEHYDE; ACROLEIN; CANNABIS; CARBONYL DERIVATIVE; FORMALDEHYDE; GLYCEROL; MACROGOL 400; MEDIUM CHAIN TRIACYLGLYCEROL; PROPYLENE GLYCOL; ALDEHYDE; MACROGOL DERIVATIVE; VEGETABLE OIL;

ARTICLE; CANNABIS SMOKING; CANNABIS USE; COMPARATIVE STUDY; HEATING; PRIORITY JOURNAL; SMOKING; VAPOR; VAPORIZATION; BIOCHEMISTRY; CHEMISTRY; ELECTRONIC CIGARETTE; HEAT; VOLATILIZATION;

ALDEHYDES; BIOCHEMICAL PHENOMENA; CANNABIS; ELECTRONIC NICOTINE DELIVERY SYSTEMS; HOT TEMPERATURE; PLANT OILS; POLYETHYLENE GLYCOLS; VOLATILIZATION;

EID: 85020793585     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2016.0337     Document Type: Article

References (51)

1. Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry 2015; 72: 1235-1242.
2. McCarthy J. One in eight U. S. adults say they smoke marijuana. Gallup website, August 8, 2016. Online document at: www. gallup. com/poll/194195/adults-say-smokemarijuana. aspx Accessed August 24, 2016.
3. Dutton S, De Pinto J, Salvanto A, Backus F. Poll: Support for legal marijuana use reaches all-time high. CBS News website, April 20, 2015. Online document at: www. cbsnews . com/news/poll-support-for-legal-marijuana-use-reaches-alltime-high Accessed July 23, 2016.
4. Jones JM. In U. S. , 58% back legal marijuana use. Gallup website, October 21, 2015. Online document at: www . gallup. com/poll/186260/back-legal-marijuana. aspx Accessed July 23, 2016.
5. Reinarman C, Nunberg H, Lanthier F, Heddleston T. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoactive Drugs 2011; 43: 128-135.
6. Troutt WD, DiDonato MD. Medical cannabis patients in Arizona: Patient characteristics, perceptions, and impressions of medical cannabis legalization. J Psychoactive Drugs 2015; 47: 259-266.
7. Moir D, Rickert WS, Levasseur G, et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol 2008; 21: 494-502.
8. Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988; 318: 347-351.
9. Callaghan RC, Allebeck P, Sidorchuk A. Cannabis use and risk of lung cancer: A 40-year cohort study of Swedish men. Eur J Public Health 2014; 24: 126.
10. Huang YH, Zhang ZF, Tashkin DP, et al. An epidemiological review of marijuana and cancer: An update. Cancer Epidemiol Biomarkers Prev 2015; 24: 15-31.
11. Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc 2013; 10: 239-247.
12. Mehra R, Moore BA, Crothers K, et al. The association between marijuana smoking and lung cancer. Arch Intern Med 2006; 166: 1359-1367.
13. Martinasek MP, McGrogan JB, Maysonet A. A systematic review of the respiratory effects of inhalational marijuana. Respir Care 2016; 61: 1543-1551.
14. Berthiller J, Straif K, Boniol M, et al. Cannabis smoking and risk of lung cancer in men: A pooled analysis of three studies in Maghreb. J Thorac Oncol 2008; 3: 1398-1403.
15. Aldington S, Harwood M, Cox B, et al. Cannabis use and risk of lung cancer: A case-control study. Eur Respir J 2008; 31: 280-286.
16. Aldington S, Williams M, Nowitz M, et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007; 62: 1058-1063.
17. Earlywine M, Barnwell SS. Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduct J 2007; 4: 11.
18. Taylor DR, Poulton R, Moffitt TE, et al. The respiratory effects of cannabis dependence in young adults. Addiction 2000; 95: 1669-1677.
19. Tetrault JM, Crothers K, Moore BA, et al. Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Arch Intern Med 2007; 167: 221-228.
20. Varlet V, Concha-Lozano N, Berthet A, et al. Drug vaping applied to cannabis: Is ''Cannavaping'' a therapeutic alternative to marijuana? Sci Rep 2016; 26: 25599.
21. GieringerDH. Cannabis ''Vaporization'': Apromising strategy for smoke harm reduction. J Cannabis Ther 2001; 1: 153-170.
22. Abrams DI, Vizoso HP, Shade SB, et al. Vaporization as a smokeless cannabis delivery system: A pilot study. Clin Pharmacol Ther 2007; 82: 52-578.
23. Baca R. Colorado shops sold more than $92 million of pot in February'16. The Cannabist website, April 13, 2016. www. Thecannabist. co/2016/04/13/colorado-marijuana-salesfebruary/51874 Accessed July 12, 2016.
24. Bingham R. Actionable insights on the Washington cannabis market. BDS Analytics website, January 14, 2016. www. bdsanalytics. com/wp-content/uploads/2015/04/1-19-16BDS-Analytics-WASHINGTON-Cannabis-Trends-FINAL . pdf Accessed August 12, 2016.
25. Sleiman M, Logue JM, Montesinos VN, et al. Emissions from electronic cigarettes: Key parameters affecting the release of harmful chemicals. Environ Sci Technol 2016; 50: 9644-9651.
26. Geiss O, Bianchi I, Barrero-Moreno J. Correlation of volatile carbonyl yields emitted by e-cigarettes with the temperature of the heating coil and the perceived sensorial quality of the generated vapours. Int J Hyg Environ Health 2016; 219: 268-277.
27. Gillman IG, Kistler KA, Stewart EW, Paolantonio AR. Effect of variable power levels on the yield of total aerosol mass and formation of aldehydes in e-cigarette aerosols. Regul Toxicol Pharmacol 2016; 75: 58-65.
28. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014; 23: 133-139.
29. Guthery W. Emissions of toxic carbonyls in an electronic cigarette. Contrib Tob Res 2016; 27: 30-37.
30. Jensen RP, Luo W, Pankow JF, et al. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 2015; 372: 392-394.
31. Kosmider L, Sobczak A, Fik M, et al. Carbonyl compounds in electronic cigarette vapors: Effects of nicotine solvent and battery output voltage. Nicotine Tob Res 2014; 16: 1319-1326.
32. Tayyarah R, Long GA. Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air. Regul Toxicol Pharmacol 2014; 70: 704-710.
33. Uchiyama S, Ohta K, Inaba Y, Kunugita N. Determination of carbonyl compounds generated from the E-cigarette using coupled silica cartridges impregnated with hydroquinone and 2, 4-dinitrophenylhydrazine, followed by high-performance liquid chromatography. Anal Sci 2013; 29: 1219-1222.
34. IARC. Monographs on the evaluation of carcinogenic risks to humans: Agents classified by the IARC monographs, vol. 1-116. International Agency for Research on Cancer website, June 24, 2016. Online document at: http://monographs. iarc. fr/ENG/Classification/index. php Accessed August 1, 2016.
35. OEHHA. Chemicals known to the state to cause cancer or reproductive toxicity. State of California Environmental Protection Agency Office of Environmental Health and Hazard Assessment website, August 5, 2016. Online document at: http://oehha. ca. gov/media/downloads/proposition-65//p65single080516. pdf Accessed August 21, 2016.
36. American Cancer Society. Formaldehyde: What is formaldehyde? American Cancer Society website, May 23, 2014. Online document at: www. cancer. org/cancer/cancercauses/othercarcinogens/intheworkplace/formaldehyde Accessed January 9, 2017.
37. Hauptmann M, Stewart PA, Lubin JH, et al. Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde. J Natl Cancer Inst 2009; 101: 1696-1708.
38. Hauptmann M, Lubin JH, Stewart PA, et al. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst 2003; 95: 1615-1623.
39. Beane Freeman L, Blair A, Lubin JH, et al. Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: The National Cancer Institute Cohort. J Natl Cancer Inst 2009; 101: 751-761.
40. Pinkerton LE, Hein MJ, Stayner LT. Mortality among a cohort of garment workers exposed to formaldehyde: An update. Occup Environ Med 2004; 61: 193-200.
41. Center for Disease Control. Occupational Health Guideline for Acetaldehyde. Center for Disease Control website, September 1978. Online document at: www. cdc. gov/niosh/docs/81-123/pdfs/0001. pdf Accessed January 9, 2017.
42. International Agency for Research on Cancer (IARC). Reevaluation of some organic chemicals, hydrazine and hydrogen peroxide. IARC Monogr Eval Carcinog Risks Hum 1999; 71: 319-325.
43. Chen C, Ferreira JCB, Gross ER, Mochly-Rosen D. Targeting aldehyde dehydrogenase 2: New therapeutic opportunities. Physiol Rev 2014; 94: 1-34.
44. USEPA. Toxicological review of acrolein. United States Environmental Protection Agency website, May 2003. Online document at: https://cfpub. epa. gov/ncea/iris/iris-documents/documents/toxreviews/0364tr. pdf Accessed August 21, 2016.
45. Feng Z, Hu W, Hu Y, Tang MS. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci USA 2006; 103: 15404-15409.
46. Wang HT, Hu Y, Tong D, et al. Effect of carcinogenic acrolein on DNA repair and mutagenic susceptibility. J Biol Chem 2012; 287: 12379-12386.
47. McPartland JM, Russo EB. Cannabis and cannabis extracts: Greater than the sum of their parts? Cannabis Ther 2001; 1: 103-132.
48. Farsalinos KE, Romagna G, Tsiapras D, et al. Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: Implications for research protocol standards definition and for public health authorities' regulation. Int J Environ Res Public Health 2013; 10: 2500-2514.
49. CORESTA. Recommended Method No. 74: Determination of Selected Carbonyls in Mainstream Cigarette Smoke by HPLC. Cooperation Centre for Scientific Research Relative to Tobacco website, July 2014. Online document at: www . coresta. org/determination-selected-carbonyls-mainstreamcigarette-smoke-high-performance-liquid-chromatography Accessed August 1, 2016.
50. Keizer RJ, Jansen RS, Rosing H, et al. Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses. Pharmacol Res Perspect 2015; 3: e00131.
51. Counts ME, Morton MJ, Laffoon SW, et al. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul Toxicol Pharmacol 2005; 41: 185-227.